Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Lucid Group acquires HealthCare21

Expands reach in UK, Asia Pacific and Middle East

- PMLiVE

Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21

Lucid Group is delighted to announce its latest acquisition, welcoming colleagues from Healthcare consultancy HealthCare21 into its magic kingdom.Over the last twelve years, Lucid Group has become well known and...

Lucid Group Communications Limited

Bear bp

Its Know Your Numbers week

Do you know yours?

Page & Page Health

What is changing in mental health and dementia care?

Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services

Wilmington Healthcare

Sanofi reception

Sanofi exits Zynquista alliance with Lexicon

Will pay $260m to end collaboration

- PMLiVE

Democrats reveal pricing plan with 250-drug hit list

Listed drugs are costing Medicare the most each year

- PMLiVE

Mallinckrodt offloads CDMO for $250m

Move follows US opioid settlement

- PMLiVE

Merck takes evobrutinib for MS into phase 3, on mixed data

First drug in class to reach this stage for the illness

Synergy Vision completes pilot of four-day working week

Agency will formalise the initiative following improved productivity

- PMLiVE

The power of high-value, highly relevant content to support clinical decisions

by Sandrine Veillet

Spotlight interview: 15 minutes on patient-centricity in pharma

Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

OPEN Health

- PMLiVE

Novartis’ CAR-T Kymriah scores SMC approval

Will now be available on NHS across the UK

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links